Clarivate
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual prop...
Latest News
4 days ago · prnewswire.com
Clarivate Announces Final Results of Offers to Purchase for Cash Certain of its Outstanding Debt SecuritiesLONDON, Nov. 12, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the expiration and final results of its previously announced cash tender offers (collectively, the "Offers") by its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the "Company"), to purchase the outstanding 3.875% Senior Secured Notes due 2028 (the "2028 Notes") for aggregate principal amount of up to $400,000,000 (the "2028 Notes Series Cap") and the outstanding 4.875% Senior Notes due 2029 (the "2029 Notes" and, together with the 2028 Notes, the "Notes" and, each, a "Series of Notes") for aggregate principal amount of up to $100,000,000 (the "2029 Notes Series Cap" and, together with the 2028 Notes Series Cap, each, a "Series Cap"), in each case upon the terms and subject to the conditions set forth in the Offer to Purchase dated November 4, 2026 (the "Offer to Purchase") and any related documents (collectively with the Offer to Purchase, the "Tender Offer Documents"). Additionally, the Company has exercised its right to increase the aggregate principal amount of 2028 Notes and 2029 Notes accepted for purchase by 2% of the outstanding aggregate principal amount of each Series of Notes, and as a result, will accept for purchase $533,000,000 total aggregate principal amount of the Notes, with the tendered 2028 Notes and 2029 Notes accepted at a proration factor of approximately 67.9% and 45.5%, respectively.
5 days ago · prnewswire.com
Clarivate to Present at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference on November 18LONDON, Nov. 11, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Matti Shem Tov, Chief Executive Officer, and Michael Easton, Executive Vice President and Chief Financial Officer, will present at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference, on Wednesday, November 18, 2026 at 2:00 pm Eastern Time. The live webcast can be accessed at https://kvgo.com/rbc/clarivate-plc-november-2026 and will be available for replay.
5 days ago · prnewswire.com
Clarivate's IPOne Connects Trusted Patent, Trademark and Litigation Intelligence to ClaudeNew Derwent patent and Darts-ip litigation connections give IP professionals access to curated patent and litigation intelligence alongside CompuMark trademark data BARCELONA, Spain, Nov. 11, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced that trusted patent and litigation intelligence from Clarivate is now available via Claude through IPOne, giving intellectual property (IP) professionals access to authoritative IP data within the AI workflows they already use. The IPOne Derwent patent and Darts-ip litigation data connectors are now listed on Anthropic's marketplace.
6 days ago · prnewswire.com
Clarivate Announces Pricing Terms of Offers to Purchase for Cash Certain of its Outstanding Debt SecuritiesLONDON, Nov. 10, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the Reference Yield with respect to the 2028 Notes and the 2028 Notes Total Consideration (as set forth in the table below) to be paid in connection with its previously announced cash tender offers (collectively, the "Offers") by its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the "Company"), to purchase the outstanding notes described below, in each case upon the terms and subject to the conditions set forth in the Offer to Purchase dated November 4, 2026 (the "Offer to Purchase"). The Company is offering to purchase in the Offers its 3.875% Senior Secured Notes due 2028 (the "2028 Notes") and its 4.875% Senior Notes due 2029 (the "2029 Notes" and, together with the 2028 Notes, the "Notes" and, each, a "Series of Notes") for the applicable consideration described below, subject to a $500,000,000 cap on the aggregate principal amount of Notes purchased in the Offers (the "Tender Cap"), proration and the terms and conditions set forth in the Offer to Purchase, including, among others, a $400,000,000 cap on the aggregate principal amount of the 2028 Notes to be purchased and a $100,000,000 cap on the aggregate principal amount of the 2029 Notes to be purchased pursuant to the Offers (each, a "Series Cap").
10 days ago · seekingalpha.com
Clarivate PLC: Return Of Organic Growth Confirms Speculative AppealClarivate PLC shares surged 40% after a solid Q3 and $600M life sciences divestment, reducing leverage and sharpening business focus. Clarivate now trades at modest valuations—2.6x sales, under 6x EBITDA, and about 3x earnings—despite only slight organic growth and persistent leverage risks. Forward guidance projects net leverage falling to 3.5–3.6x and free cash flow rising to $350–$400M by 2027, supporting a more manageable debt profile.
13 days ago · prnewswire.com
Clarivate Commences Offers to Purchase for Cash Certain of its Outstanding Debt Securities/PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its wholly-owned
13 days ago · marketbeat.com
What Clarivate (CLVT) Said on Its Q3 Earnings CallClarivate NYSE: CLVT said it completed the sale of its Life Sciences & Healthcare segment ahead of schedule during the third quarter, leaving the company focused on its Academia & Government and Intellectual Property businesses. Management said the reshaped company has approximately $2 billion in revenue, with recurring organic revenue representing 93% of the total.
14 days ago · seekingalpha.com
Clarivate Plc (CLVT) Q3 2026 Earnings Call TranscriptClarivate Plc (CLVT) Q3 2026 Earnings Call Transcript
14 days ago · zacks.com
Clarivate PLC (CLVT) Beats Q3 Earnings EstimatesClarivate PLC (CLVT) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.18 per share a year ago.
14 days ago · prnewswire.com
Clarivate Reports Third Quarter 2026 Results, Delivering Clear Path to Value Creation— Improved recurring organic revenue growth driven by portfolio transformation and AI-led innovation — — Updates 2026 financial outlook following the divestiture of Life Sciences & Healthcare segment — LONDON, Nov. 3, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the third quarter ended September 30, 2026. Executive Commentary Matti Shem Tov, Chief Executive Officer: "Third quarter results continued to improve across key metrics, including organic recurring revenue growth and the return to positive ACV growth in the Intellectual Property segment.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove CLVT